Yao, Xinyi
https://orcid.org/0000-0002-7371-0885
Mayo Clinic
Takeda Development Center Americas Inc., Cambridge, USA
Citations 1
P499 Efficacy and safety of 2 or 3 vedolizumab intravenous infusions as induction therapy for ulcerative colitis and Crohn’s disease: results from VISIBLE 1 and 2
Sandborn, William J. , Wolf, Douglas C. , Yao, Xinyi , Kisfalvi, Krisztina, Vermeire, Séverine , Loftus, Edward V. , Danese, Silvio , Chen, Jingjing , Vermeire, Séverine
Journal of Crohn's and Colitis | January 25, 2019 | Volume: 13 | Issue: Supplement_1 | Pages: S361-S362
